We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A fiscal 2017 agricultural appropriations bill that breezed through its first congressional hurdle Wednesday proposes a slight funding increase for the FDA, but is still well below the agency’s funding request. Read More
The Office of Generic Drugs had a banner year in 2015, seeing more than 700 full and tentative approvals, the agency announced yesterday in its first-ever report on generics. Read More
It took a few days and a threatened contempt of Congress citation, but Valeant Pharmaceuticals International’s CEO J. Michael Pearson has agreed to meet with Senate officials investigating rising prescription drug prices. Read More